Pancreatic gastrin-producing neuroendocrine tumor

disease
On this page

Also known as gastrin-producing neuroendocrine tumor of pancreasgastrin-producing neuroendocrine tumour of pancreasislet cell tumor, ulcerogenicpancreas gastrin-producing neuroendocrine tumorpancreas gastrin-producing neuroendocrine tumourpancreatic G-cell tumourpancreatic gastrin producing NETpancreatic gastrin producing tumorpancreatic gastrin producing tumour

Summary

Pancreatic gastrin-producing neuroendocrine tumor (MONDO:0003525) is a cancer. A subtype of gastrin-producing neuroendocrine tumor — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namepancreatic gastrin-producing neuroendocrine tumor
Mondo IDMONDO:0003525
MeSHD015408
DOIDDOID:5580
NCITC9069
UMLSC1368066
MedGen235080
GARD0023548
Anatomy (UBERON)UBERON:0001264
Is cancer (heuristic)yes

Also known as: gastrin-producing neuroendocrine tumor of pancreas · gastrin-producing neuroendocrine tumour of pancreas · islet cell tumor, ulcerogenic · pancreas gastrin-producing neuroendocrine tumor · pancreas gastrin-producing neuroendocrine tumour · pancreatic G-cell tumour · pancreatic gastrin producing NET · pancreatic gastrin producing tumor · pancreatic gastrin producing tumour · pancreatic gastrin-producing neuroendocrine tumor

Disease family

This is a subtype of gastrin-producing neuroendocrine tumor. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorderdigestive system neuroendocrine neoplasmdigestive system neuroendocrine tumor, grade 1/2gastrin-producing neuroendocrine tumorpancreatic gastrin-producing neuroendocrine tumor

Related subtypes (2): gastric gastrin-producing neuroendocrine tumor, duodenal gastrin-producing neuroendocrine tumor

Subtypes (1): pancreatic gastrinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

Drugs indicated for this disease

No approved or late-stage (phase ≥3) drug is indicated for this disease; the following are in earlier-phase trials only.

Earlier-phase candidates (phase 2, investigational — efficacy not yet established): Omeprazole, Pantoprazole.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.